| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 3062P60MH9 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Lymphoma | 3 | D008223 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Waldenstrom Macroglobulinemia | 2 | D008258 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 2 | D015456 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 205923-57-5 |
| ChEMBL | CHEMBL2108404 |
| FDA SRS | 3062P60MH9 |
| Guide to Pharmacology | 8088 |
CONTENTS